17th May 2006 10:19
Biofutures International plc17 May 2006 For Immediate Release 17 May 2006 Biofutures International plc Holding(s) in Company Biofutures International plc ("the Company") has today been notified pursuant tosection 198 of the Companies Act 1985 ("the Act") that as at close of businesson 5 May 2006, The Goldman Sachs Group, Inc. ("GS Inc.") was interested, byattribution only, in a total of 2,650,000 shares, representing approximately7.19% of the issued share capital of the Company. Of these 2,650,000 shares: • The interest in 150,000 shares arose from a beneficial interest held by Goldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. These shares are, or will be registered at CREST in account CREPTEMP. • The interest in 2,500,000 shares arose from an interest held by Goldman, Sachs & Co., a wholly-owned subsidiary of GS Inc, acting as custodian for its customers. These shares are, or will be, registered in the name of Goldman Sachs Securities (Nominees) Limited. - Ends - For further information, please contact: Buchanan Communications 0207 466 5000Suzanne Brocks This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Graphene Nanochem